Works matching DE "GENERIC drugs"


Results: 3672
    1
    2
    3
    4
    5
    6
    7
    8

    High costs for seniors.

    Published in:
    Fraser Forum, 2009, p. 24
    By:
    • Skinner, Brett J.;
    • Rovere, Mark
    Publication type:
    Article
    9
    10

    Erratum.

    Published in:
    2008
    Publication type:
    Correction Notice
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Carta a los lectores.

    Published in:
    Historia Crítica, 2017, n. 65, p. 9, doi. 10.7440/histcrit65.2017.00
    By:
    • Cristina Pérez, María
    Publication type:
    Article
    20
    21
    22

    Generic medications for hepatitis C.

    Published in:
    Liver International, 2016, v. 36, n. 7, p. 925, doi. 10.1111/liv.13120
    By:
    • Jensen, Donald M.;
    • Sebhatu, Phoebe;
    • Reau, Nancy S.
    Publication type:
    Article
    23

    YOUR MEDICATION INFORMATION.

    Published in:
    Brown University Psychopharmacology Update, 2023, v. 34, n. 9, p. 9, doi. 10.1002/pu.31067
    Publication type:
    Article
    24

    Your Medication Information.

    Published in:
    Brown University Psychopharmacology Update, 2023, v. 34, n. 7, p. 9, doi. 10.1002/pu.31042
    Publication type:
    Article
    25
    26

    Your Medication Information.

    Published in:
    Brown University Psychopharmacology Update, 2022, v. 33, n. 2, p. 9, doi. 10.1002/pu.30836
    Publication type:
    Article
    27

    Your Medication Information.

    Published in:
    Brown University Psychopharmacology Update, 2020, v. 31, n. 12, p. 9, doi. 10.1002/pu.30662
    Publication type:
    Article
    28

    The 2020 election commentary.

    Published in:
    Brown University Psychopharmacology Update, 2020, v. 31, n. 11, p. 7, doi. 10.1002/pu.30645
    By:
    • Price, Lawrence H.
    Publication type:
    Article
    29
    30
    31

    Modafinil Provigil.

    Published in:
    Brown University Psychopharmacology Update, 2015, v. 26, p. 1
    Publication type:
    Article
    32

    From the FDA.

    Published in:
    Brown University Psychopharmacology Update, 2014, v. 25, n. 4, p. 8
    Publication type:
    Article
    33
    34
    35
    36
    37
    38

    From the FDA.

    Published in:
    Brown University Psychopharmacology Update, 2013, v. 24, n. 1, p. 8
    Publication type:
    Article
    39
    40

    From the FDA.

    Published in:
    Brown University Psychopharmacology Update, 2012, v. 23, n. 11, p. 8
    Publication type:
    Article
    41

    New approvals.

    Published in:
    Brown University Psychopharmacology Update, 2012, v. 23, n. 5, p. 8
    Publication type:
    Article
    42

    From the FDA.

    Published in:
    Brown University Psychopharmacology Update, 2012, v. 23, n. 4, p. 8
    Publication type:
    Article
    43

    From the FDA.

    Published in:
    Brown University Psychopharmacology Update, 2012, v. 23, n. 3, p. 8
    Publication type:
    Article
    44

    From the FDA.

    Published in:
    Brown University Psychopharmacology Update, 2012, v. 23, n. 2, p. 8
    Publication type:
    Article
    45

    From the FDA.

    Published in:
    Brown University Psychopharmacology Update, 2011, v. 22, n. 7, p. 8
    Publication type:
    Article
    46
    47
    48
    49

    Anti-Competitive Impact of Pseudo-Generics.

    Published in:
    Journal of Industry, Competition & Trade, 2014, v. 14, n. 1, p. 83, doi. 10.1007/s10842-013-0154-0
    By:
    • Rodrigues, Vasco;
    • Gonçalves, Ricardo;
    • Vasconcelos, Hélder
    Publication type:
    Article
    50